Ying Liang
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 9
- Oncology top 2%
- Peptidase Inhibition and Analysis 11
- Molecular Biology top 5%
- RNA modifications and cancer 20
- Coenzyme Q10 studies and effects 10
- RNA Research and Splicing 9
- Epigenetics and DNA Methylation 9
- Cancer-related gene regulation 8
- Immunology top 5%
- Otorhinolaryngology top 5%
Ying Liang
158 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 147
- Cancer Research 1.1k
- Oncology 1.2k
- Molecular Biology 2.3k
- Immunology 618
- Otorhinolaryngology 95
Countries citing papers authored by Ying Liang
This map shows the geographic impact of Ying Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Liang more than expected).
Fields of papers citing papers by Ying Liang
This network shows the impact of papers produced by Ying Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Liang. The network helps show where Ying Liang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ying Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 42 | |
| 12 | MiR-34a Inhibits Cell Proliferation and Induces Apoptosis in Human Nasopharyngeal Carcinoma by Targeting lncRNA MCM3AP-AS1 | 2020 | 1 |
| 13 | 2019 | 38 | |
| 14 | 2018 | 21 | |
| 15 | 2018 | 38 | |
| 16 | 2015 | 19 | |
| 17 | 2010 | 1 | |
| 18 | 2007 | 50 | |
| 19 | Prevention and treatment on colibacillosis & pullorosis with extracts from Scutellaria baicalensis Georgi in chickens | 2007 | 1 |
| 20 | 2006 | 197 |
About Ying Liang
Ying Liang is a scholar working on Cancer Research, Biochemistry and Oncology, having authored 170 papers that have together received 4.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (20 papers), Cancer-related molecular mechanisms research (12 papers), Peptidase Inhibition and Analysis (11 papers), Coenzyme Q10 studies and effects (10 papers), MicroRNA in disease regulation (9 papers), RNA Research and Splicing (9 papers), Epigenetics and DNA Methylation (9 papers) and Cancer-related gene regulation (8 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.2k citations) and Molecular Biology (2.3k citations). Ying Liang has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Yu‐Sun Chang, Jau‐Song Yu, Kai‐Ping Chang, Chuen Hsueh, Chih‐Ching Wu, Kwang‐Huei Lin, Lih‐Chyang Chen, Ya‐Hui Huang, Tsann‐Long Hwang and Lang‐Ming Chi. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.